S100A proteins as molecular targets in the ocular surface inflammatory diseases

Ocular Surface

Volumn 12, Issue 1, 2014, Pages 23-31

  Tong, Louis ^a,b,c,d   Lan, Wanwen ^a   Lim, Rayne R ^a   Chaurasia, Shyam S ^a,c,d  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Corneal angiogenesis; Dry eye; Meibomian gland disease; Meibomian gland dysfunction; Ocular surface; Pterygium; S100A proteins

Indexed keywords

CALGRANULIN A; CALGRANULIN B; OLOPATADINE; PSORIASIN; TOLL LIKE RECEPTOR;

ARTICLE; CORNEA NEOVASCULARIZATION; DRY EYE; HUMAN; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; KERATITIS; MEIBOMIAN GLAND; MEIBOMIAN GLAND DYSFUNCTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OCULAR SURFACE DISEASE; PTERYGIUM;

CB-CORNV; CHEMICAL BURN-INDUCED CORNEAL NEOVASCULARIZATION; CK; CORNEAL ANGIOGENESIS; CYTOKERATIN; DRY EYE; HNP; HUMAN NEUTROPHIL PEPTIDE; IL; INTERLEUKIN; ISOBARIC TAGGING FOR RELATIVE AND ABSOLUTE QUANTIFICATION; ITRAQ; MACROPHAGE INFLAMMATORY PROTEIN 2; MAPK; MATRIX METALLOPROTEINASES; MEIBOMIAN GLAND DISEASE; MEIBOMIAN GLAND DYSFUNCTION; MGD; MIP-2; MITOGEN-ACTIVATED PROTEIN KINASE; MMPS; NFΚ; NUCLEAR FACTOR KAPPA; OCULAR SURFACE; ORM1; PIP; PROLACTIN-INDUCIBLE PROTEIN; PTERYGIUM; RAGE; REACTIVE OXYGEN SPECIES; RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS; ROS; S-CORNV; S100A PROTEINS; SCC; SELDI-TOF-MS; SQUAMOUS CELL CARCINOMA; SURFACE-ENHANCED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY; SUTURE-INDUCED CORNEAL NEOVASCULARIZATION; TIRAP; TLR; TNF-Α; TOLL-INTERLEUKIN 1 RECEPTOR DOMAIN-CONTAINING ADAPTOR PROTEIN; TOLL-LIKE RECEPTOR; TUMOR NECROSIS FACTOR-Α; ULTRAVIOLET; UV; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF; Α1-ACID GLYCOPROTEIN 1;

ANIMALS; ANTIBODIES; CALGRANULIN A; CALGRANULIN B; DRY EYE SYNDROMES; EPITHELIUM, CORNEAL; HUMANS; KERATITIS; PTERYGIUM;

EID: 84893810350     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtos.2013.10.001     Document Type: Review

References (72)

1. Heizmann CW, Fritz G, Schafer BW. S100 proteins: Structure, functions and pathology. Front Biosci 2002;7:1356-68
2. Lesniak W, Kuznicki J. Regulation of protein S100 expression during transcription. Postepy Hig Med Dosw 1999;53:183-93
3. Lim SY, Raftery MJ, Goyette J, et al. Oxidative modifications of S100 proteins: Functional regulation by redox. J Leukoc Biol 2009;86:577-87
4. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-51
5. Donato R, Cannon BR, Sorci G, et al. Functions of S100 proteins. Curr Mol Med 2013;13:24-57
6. Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: An update. Biochim Biophys Acta 2009;1793:993-1007
7. Rezvanpour A, Shaw GS. Unique S100 target protein interactions. Gen Physiol Biophys 2009;28:39-46
8. Eckert RL, Broome AM, Ruse M, et al. S100 proteins in the epidermis. J Invest Dermatol 2004;123:23-33
9. Emberley ED, Murphy LC, Watson PH. S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 2004;82: 508-15
10. Zimmer DB, Dubuisson JG. Identification of an S100 target protein: Glycogen phosphorylase. Cell Calcium 1993;14:323-32
11. Miwa N, Uebi T, Kawamura S. S100-annexin complexesebiology of conditional association. FEBS J 2008;275:4945-55
12. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: A novel group of proinflammatory molecules. Trends Immunol 2003;24:155-8
13. Lukanidin E, Sleeman JP. Building the niche: The role of the S100 proteins in metastatic growth. Semin Cancer Biol 2012;22:216-25
14. Manolakis AC, Kapsoritakis AN, Tiaka EK, Potamianos SP. Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci 2011;56:1601-11
15. Yammani RR. S100 proteins in cartilage: Role in arthritis. Biochim Biophys Acta 2012;1822:600-6
16. Xie XL, Tang ZG, Yao ZG. Expression of S100 in oral submucose fibrosis. Hunan Yi Ke Da Xue Xue Bao 2003;28:388-90
17. Schaub MC, Heizmann CW. Calcium, troponin, calmodulin, S100 proteins: From myocardial basics to new therapeutic strategies. Biochem Biophys Res Commun 2008;369:247-64
18. Marshak DR, Pena LA. Potential role of S100 beta in Alzheimer's disease: An hypothesis involving mitotic protein kinases. Prog Clin Biol Res 1992;379:289-307
19. Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003;60:569-80
20. Perera C, McNeil HP, Geczy CL. S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 2010;88:41-9
21. Geerling G, Liu CS, Collin JR, Dart JK. Costs and gains of complex procedures to rehabilitate end stage ocular surface disease. Br J Ophthalmol 2002;86:1220-1
22. NussenblattR.The expanding use ofimmunosuppression in the treatment of non-infectious ocular disease. J Autoimmun 1992;5(Suppl A):247-57
23. Li J, Riau AK, Setiawan M, et al. S100A expression in normal corneallimbal epithelial cells and ocular surface squamous cell carcinoma tissue. Mol Vis 2011;17:2263-71
24. Amescua G, Miller D, Alfonso EC. What is causing the corneal ulcer? Management strategies for unresponsive corneal ulceration. Eye (Lond) 2012;26:228-36
25. Zhao J, Endoh I, Hsu K, et al. S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma. Antioxid Redox Signal 2011;14:1589-600
26. Harrison CA, Raftery MJ, Walsh J, et al. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J Biol Chem 1999;274:8561-9
27. Lim SY, Raftery M, Cai H, et al. S-nitrosylated S100A8: Novel anti-inflammatory properties. J Immunol 2008;181:5627-36
28. Loser K, Vogl T, Voskort M, et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8 T cells. Nat Med 2010;16:713-7
29. Smolenska Z, Pawlowska J, Zdrojewski Z, et al. Increased percentage of CD8-CD28- T cells correlates with clinical activity in primary Sjogren's syndrome. Cell Immunol 2012;278(1-2):143-51
30. Hegyi Z, Zwicker S, Bureik D, et al. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol 2012;132:1416-24
31. Yano J, Kolls JK, Happel KI, et al. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One 2012;7(9):e46311. http://dx.doi.org/10.1371/journal. pone.0046311. Epub 2012 Sep 25
32. Yano J, Noverr MC, Fidel Jr PL. Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins. Cytokine 2012;58:118-28
33. Madsen P, Rasmussen HH, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991;97:701-12
34. Glaser R, Harder J, Lange H, et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005;6:57-64
35. Abtin A, Eckhart L, Mildner M, et al. Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. FASEB J 2008;22:2168-76
36. Garreis F, Gottschalt M, Schlorf T, et al. Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus. Invest Ophthalmol Vis Sci 2011;52:4914-22
37. (No authors listed) The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007;5:75-92
38. Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res 2009;8:4889-905
39. Zhang G, Li M, Jin J, et al. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Asian Pac J Cancer Prev 2011;12:2075-80
40. Sinha P, Okoro C, Foell D, et al. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 2008;181:4666-75
41. Huet E, Vallee B, Delbe J, et al. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: Implications in dry eye disease. Am J Pathol 2011;179:1278-86
42. Pelegrino FS, Pflugfelder SC, De Paiva CS. Low humidity environmental challenge causes barrier disruption and cornification of the mouse corneal epithelium via a c-jun N-terminal kinase 2 (JNK2) pathway. Exp Eye Res 2012;94:150-6
43. Sunahori K, Yamamura M, Yamana J, et al. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogenactivated protein kinase in rheumatoid arthritis. Arthritis Res Ther 2006;8:R69
44. Kwon CH, Moon HJ, Park HJ, et al. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-kappaB activation in gastric cancer cells. Mol Cells 2013;35:226-34
45. Uchino Y, Kawakita T, Miyazawa M, et al. Oxidative stress induced inflammation initiates functional decline of tear production. PLoS One 2012;7:e45805
46. Uchino Y, Kawakita T, Ishii T, et al. A new mouse model of dry eye disease: Oxidative stress affects functional decline in the lacrimal gland. Cornea 2012;31(Suppl 1):S63-7
47. Ghavami S, Eshragi M, Ande SR, et al. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 2010;20:314-31
48. Zhang X, Chen W, De Paiva CS, et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci 2011;52:6279-85
49. Wong TT, Zhou L, Li J, et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci 2011;52:7385-91
50. Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol 1975;59:667-9
51. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee. Invest Ophthalmol Vis Sci 2011;52: 1930-7
52. Tong L, Zhou L, Beuerman RW, et al. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol 2011;95:848-52
53. Knop N, Knop E. Meibomian glands. Part I: Anatomy, embryology and histology of the Meibomian glands. Ophthalmologe 2009;106:872-83
54. Liu S, Richards SM, Lo K, et al. Changes in gene expression in human meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011;52: 2727-40
55. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: Current concepts and their therapeutic implications. Ocul Surf 2008;6:24-43
56. Grimbaldeston MA, Geczy CL, Tedla N, et al. S100A8 induction in keratinocytes by ultraviolet A irradiation is dependent on reactive oxygen intermediates. J Invest Dermatol 2003;121:1168-74
57. Riau AK, Wong TT, Beuerman RW, Tong L. Calcium-binding S100 protein expression in pterygium. Mol Vis 2009;15:335-42
58. Di Nuzzo S, Sylva-Steenland RM, Koomen CW, et al. Exposure to UVB induces accumulation of LFA-1- T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem Photobiol 2000;72:374-82
59. Awdeh RM, DeStafeno JJ, Blackmon DM, et al. The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: Evaluation of the inflammatory response. Adv Ther 2008;25:479-87
60. Zhou L, Beuerman RW, Ang LP, et al. Elevation of human alphadefensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest Ophthalmol Vis Sci 2009;50:2077-86
61. Deng Q, Sun M, Yang K, et al. MRP8/14 enhances corneal susceptibility to Pseudomonas aeruginosa Infection by amplifying inflammatory responses. Invest Ophthalmol Vis Sci 2013;54:1227-34
62. Regenfuss B, Bock F, Cursiefen C. Corneal angiogenesis and lymphangiogenesis. Curr Opin Allergy Clin Immunol 2012;12:548-54
63. Shubbar E, Vegfors J, Carlstrom M, et al. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Res Treat 2012;134:71-80
64. Li C, Zhang F, Wang Y. S100A proteins in the pathogenesis of experimental corneal neovascularization. Mol Vis 2010;16:2225-35
65. Bjork P, Bjork A, Vogl T, et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol 2009;7:e97
66. Ye F, Foell D, Hirono KI, et al. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004;94:840-4
67. Markowitz J, MacKerell Jr AD, Weber DJ. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins. Mini Rev Med Chem 2007;7:609-16
68. Lee SW, Tomasetto C, Swisshelm K, et al. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci U S A 1992;89: 2504-8
69. Loskutova LV, Shtark MB, Epstein OI. Efficiency of ultralow doses of antibodies to S100 protein and delta sleep-inducing peptide in rats with anxious depression. Bull Exp Biol Med 2003;135(Suppl 7):20-2
70. Nikitin VP, Kozyrev SA, Shevelkin AV, Sherstnev VV. The effects of antibodies against proteins of the s100 group on neuron plasticity in sensitized and non-sensitized snails. Neurosci Behav Physiol 2002;32: 25-31
71. Okada M, Tokumitsu H, Kubota Y, Kobayashi R. Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: Identification of putative drug binding sites on S100A1 protein. Biochem Biophys Res Commun 2002;292:1023-30
72. Putranto EW, Murata H, Yamamoto K, et al. Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization. Int J Mol Med 2013;32:938-44